Protalix Company

Protalix is a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system. Its pipeline consists of proprietary, potentially clinically superior versions of recombinant therapeutic proteins that target established pharmaceutical markets.

Funding Status: IPO
Headquarters: Carmiel, Israel
Founded Date: 1993
Investor Type: N/A
Investment Stage: N/A
Technology: Biotechnology, Pharmaceutical, Therapeutics
Employee Number: 200-500
Number Of Exists: N/A
Industry: Personalized Medicine